Effects of Adriamycin-Cytoxan chemotherapy on hematological and electrolyte parameters among breast cancer patients

Overview of attention for article published in Frontiers in oncology, May 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 1 X post from an account with 6,551 followers.

New research: Effects of Adriamycin-Cytoxan chemotherapy on hematological and electrolyte parameters among breast cancer patients: Background Adriamycin-Cytoxan (AC) is a common chemotherapy treatment for breast cancer (BC) patients. Its… #oncology https:

14 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.